Clinical outcomes
| Characteristic | Frequency, n (%) |
| Immediate neurological adverse events (<24 hours) | 2 (2.0) |
| Early neurological adverse events (<30 days) | 3 (3.0) |
| Late neurological adverse events (>30 days) | 2 (2.0) |
| Modified Rankin Scale at 6 months: | |
| 0 | 98 (97%) |
| 1 | 3 (3%) |
| 2–6 | 0 (0%) |
| Mortality | 0 (0) |
| Complete occlusion | |
| 1 month | 63 (54.7) |
| 3 months | 83 (72.1) |
| 6 months | 94 (81.7) |
| In-stent stenosis at 6 months >50% | 6 (5.9) |
| Stent occlusion | 1 (1.0) |